Trevi Therapeutics Inc (NASDAQ:TRVI)

2.60
BATS BZX Real-Time Price
As of 10:38am ET
 +0.16 / +6.56%
Today’s Change
1.43
Today|||52-Week Range
4.68
+34.72%
Year-to-Date

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Trevi Therapeutics Inc have a median target of 7.50, with a high estimate of 9.00 and a low estimate of 6.00. The median estimate represents a +188.46% increase from the last price of 2.60.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Trevi Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.09
Sales
$0.00
Reporting Date
Aug 16

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -41.67%
 
 
 
 
 
 
Growthannually 20.74%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.